dolichodial: isolated from walkingstick, Anisomorpha buprestoides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
dolichodial : A dialdehyde that is cyclopentanecarbaldehyde substituted by a methyl group at position 2 and a 3-oxo-prop-1-en-2yl group at position 5. It has been found to occur in pheromones of insects such as aphids. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 442422 |
| CHEBI ID | 4685 |
| SCHEMBL ID | 24228257 |
| MeSH ID | M0493600 |
| Synonym |
|---|
| (1r,2s,5s)-2-methyl-5-(3-oxoprop-1-en-2-yl)cyclopentanecarbaldehyde |
| CHEBI:4685 |
| (1r,2s,5s)-2-(1-formylvinyl)-5-methylcyclopentanecarbaldehyde |
| iridial |
| dolichodial |
| C09777 |
| 5951-57-5 |
| (1r,2s,5s)-2-(1-formylethenyl)-5-methylcyclopentanecarbaldehyde |
| LMPR0102070037 |
| (1s,2r,3s)-2-formyl-3-methyl-.alpha.-methylenecyclopentaneacetaldehyde |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-.alpha.-methylene-, (1s,2r,3s)- |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-.alpha.-methylene-, (1s-(1.alpha.,2.alpha.,3.beta.))- |
| dolichodial, (-)- |
| unii-1klh0pk5rs |
| (-)-dolichodial |
| dolichodial (1s,2r,3s)-form [mi] |
| (1s,2r,3s)-dolichodial |
| 1klh0pk5rs , |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-alpha-methylene-, (1s,2r,3s)- |
| 60478-52-6 |
| dolichodial [mi] |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-.alpha.-methylene-, (1.alpha.,2.alpha.,3.beta.)- |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-.alpha.-methylene-, (1r,2s,3r)-rel- |
| (+/-)-dolichodial |
| 2-formyl-3-methyl-.alpha.-methylenecyclopentaneacetaldehyde |
| D08WL9YC5Q , |
| (cis,trans)-dolichodial |
| DTXSID00331826 |
| 2-formyl-3-methyl-alpha-methylenecyclopentaneacetaldehyde |
| unii-d08wl9yc5q |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-alpha-methylene-, (1r,2s,3r)-rel- |
| cyclopentaneacetaldehyde, 2-formyl-3-methyl-alpha-methylene-, (1alpha,2alpha,3beta)- |
| 1198-22-7 |
| SCHEMBL24228257 |
| Role | Description |
|---|---|
| animal metabolite | Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals. |
| plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
| volatile oil component | Any plant metabolite that is found naturally as a component of a volatile oil. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| dialdehyde | Any aldehyde with two aldehyde groups. |
| olefinic compound | Any organic molecular entity that contains at least one C=C bond. |
| iridoid monoterpenoid | One of a class of monoterpenoids biosynthesized from isoprene and often intermediates in the biosynthesis of alkaloids. Iridoids usually consist of a cyclopentane ring fused to a six-membered oxygen heterocycle; cleavage of a bond in the cyclopentane ring gives rise to the subclass known as secoiridoids. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||